Insider Transactions in Q3 2022 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2022
|
Kenneth Carl Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,424
+0.78%
|
$4,272
$3.55 P/Share
|
|
Jul 01
2022
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,372
+37.93%
|
$10,976
$8.03 P/Share
|
|
Jul 01
2022
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,246
+1.37%
|
$9,968
$8.03 P/Share
|